Ascletis seeks authorization for Ritonavir in Hong Kong

Ascletis Pharma has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the H...

April 4, 2022 | Monday | News
China approves clinical trial for CanSinoBIO's COVID-19 mRNA vaccine

CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...

April 5, 2022 | Tuesday | News
China backs 'Tai Chi Training' to improve Parkinson's Disease and mild cognitive impairment

The latest research shows that Tai Chi training (an internal Chinese martial art) is conducive to the treatment of Parki...

April 1, 2022 | Friday | News
Zhimeng Biopharma begins Phase I trial of Hep B drug

China's Zhimeng Biopharma, Inc., an innovation-driven biopharmaceutical company focused on the development of innovative...

April 1, 2022 | Friday | News
UMP Healthcare expands free telemedicine and drug delivery to COVID-19 patients

Hong Kong based UMP Healthcare Holdings Limited has announced the results of a recent service survey, which found that a...

April 1, 2022 | Friday | News
JW Therapeutics announces IND approval of Carteyva

China's JW Therapeutics has received the Investigational New Drug (IND) clearance from the National Medical Products Adm...

March 31, 2022 | Thursday | News
CStone starts phase I trial of cancer drug

China's CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercial...

March 31, 2022 | Thursday | News
Hong Kong study links dry eye disease with COVID-19

Some COVID-19 patients develop various and persistent symptoms weeks and months after completely recovering from the inf...

March 31, 2022 | Thursday | News
Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology

China's Biosion, Inc., and US' Pyxis Oncology have entered into an agreement under which Pyxis Oncology will be granted ...

March 30, 2022 | Wednesday | News
CellOrigin raises new funds to Jump-start iPSC immune cell therapy products toward clinics

China's CellOrigin Inc, a biotech company focusing on iPSC-derived immune cell therapies, announced it secured a new rou...

March 30, 2022 | Wednesday | News
China advances commercialisation of long-acting COVID-19 neutralising antibody therapy

Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is p...

March 30, 2022 | Wednesday | News
Taiwan accepts CANbridge's NDA for Alagille Syndrome

CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...

March 29, 2022 | Tuesday | News
China's Biocytogen expands global footprint with opening of innovation centre in Germany

Biocytogen Pharmaceuticals (Beijing) Co., has announced the opening of the Biocytogen Europe Innovation Centre (BEIC) in...

March 29, 2022 | Tuesday | News
InnoCare announces approval of Clinical Trial of TYK2 JH2 allosteric Inhibitor ICP-488 in China

InnoCare Pharma has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical P...

March 28, 2022 | Monday | News
China's Innovent Biologics expands oncology partnership with Eli Lilly for $45M

Innovent Biologics and Eli Lilly and Company have announced that the companies will now expand the strategic partnership...

March 28, 2022 | Monday | News
Chinese startup iMeddy provides free video medical consultation to COVID-19 patients

Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University...

March 25, 2022 | Friday | News
Insilico Medicine partners with EQRx for AI-driven drug discovery

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...

March 25, 2022 | Friday | News
Hong Kong builds 'Rehab 8 Forms' programme to aid post-COVID-19 recovery

After two years of battling the COVID-19 pandemic, the World Health Organization (WHO) has suggested that while most peo...

March 24, 2022 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls